Marao, Taiba H.

HRN: 132647  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2022
MUPIROCIN 2%, 15G (TUBE)
04/09/2022
04/16/2022
TOPICAL
2%
TID
Infected Bed Sores, DM Type II
Waiting Final Action 
04/14/2022
LEVOFLOXACIN 500MG (TAB)
04/14/2022
04/24/2022
NGT
500mg 1 And 1/2 Tab
OD
Sepsis Sec To Worsening HAP/VAP, Decubitus Ulcer
Waiting Final Action 
04/09/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/09/2022
04/15/2022
IV
4.5 Grams
Q6h
Pneumonia. Complicated UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: